MedPath
NMPA Approval

Milnacipran Hydrochloride Tablets

国药准字H20243552

April 24, 2024

Drug Information

盐酸米那普仑片

片剂

25mg

化学药品

April 24, 2024

Company Information

Applicant Company

石家庄经济技术开发区塔西大街6号

Manufacturing Company

石家庄经济技术开发区塔西大街6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸米那普仑片 - NMPA 批准文号 | MedPath